Back
Global X Gold Producer Eq Cov Call ETF Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
29
GLCC.TO
Global X Gold Producer Eq Cov Call ETF
Last Price:
27.38
Seasonality Move:
1.72%
Sell
2
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
12.89%
Sell
29
Global X Gold Producer Eq Cov Call ETF (GLCC.TO)
is a Sell
Is Global X Gold Producer Eq Cov Call ETF a Buy, Sell or Hold?
- The current Global X Gold Producer Eq Cov Call ETF [GLCC.TO] share price is $27.38. The Score for GLCC.TO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- GLCC.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GLCC.TO Stock Price Chart
What is Global X Gold Producer Eq Cov Call ETF's stock price today?
-
The Global X Gold Producer Eq Cov Call ETF share price today is $27.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLCC.TO is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLCC.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 46.04 | Sell |
Chaikin Money Flow: | -26677 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.74 - 28.06) | Sell |
Bollinger Bands (100): | (26.98 - 29.68) | Sell |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.2 | Sell |
Relative Strength Index (14 RSI): | 28.25 | Sell |
Chaikin Money Flow: | 740295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.22 - 61.14) | Sell |
Bollinger Bands (100): | (41.85 - 53.15) | Sell |
GLCC.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.81 | Sell |
20-day SMA: | 27.65 | Sell |
50-day SMA: | 28.58 | Sell |
200-day SMA: | 26.67 | Buy |
8-day EMA: | 27.83 | Sell |
20-day EMA: | 27.81 | Sell |
50-day EMA: | 28.12 | Sell |
200-day EMA: | 26.93 | Buy |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.4 | Sell |
20-day SMA: | 53.73 | Sell |
50-day SMA: | 49.6 | Sell |
200-day SMA: | 41.93 | Sell |
8-day EMA: | 46.69 | Sell |
20-day EMA: | 51.08 | Sell |
50-day EMA: | 50.45 | Sell |
200-day EMA: | 42.79 | Sell |
Global X Gold Producer Eq Cov Call ETF Earnings Growth & GLCC.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Global X Gold Producer Eq Cov Call ETF Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |